Literature DB >> 30637269

Possible Post-Traumatic Focal Dystonia Associated with Tau Pathology Localized to Putamen-Globus Pallidus.

Diego Iacono1,2,3,4,5, Patricia Lee1,4, Mark Hallett6, Daniel Perl1,3.   

Abstract

BACKGROUND: Dystonia is often associated with damage to basal ganglia (BG), but neuropathological assessments of these cases are infrequent.
METHODS: A brain was assessed with possible post-traumatic focal dystonia that appeared after an accident occurred during childhood.
RESULTS: Tau pathology was found within putamen and globus pallidus of the right hemisphere, and chronic traumatic encephalopathy (CTE) was observed in the cortex of the left hemisphere. No diffuse axonal injury (DAI), β-amyloid, ubiquitin, p62, or pTDP43 pathology was found.
CONCLUSIONS: Post-traumatic dystonia could be associated with post-traumatic tau pathology formation. However, more cases are necessary to establish causality. The tau lesions found in the BG of this patient did not fit within CTE criteria. We hypothesize that due to the anatomo-histological characteristics of the BG, tau pathology associated with brain traumas produce histopathological patterns different from sulcal-tau pathology, which is the only tau pathology distribution currently accepted as pathognomonic of CTE.

Entities:  

Keywords:  CTE spectrum; basal ganglia; post‐traumatic dystonia; tau pathology; traumatic brain injury

Year:  2018        PMID: 30637269      PMCID: PMC6207110          DOI: 10.1002/mdc3.12626

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  36 in total

Review 1.  Epidemiology of primary dystonia.

Authors:  Giovanni Defazio; Giovanni Abbruzzese; Paolo Livrea; Alfredo Berardelli
Journal:  Lancet Neurol       Date:  2004-11       Impact factor: 44.182

2.  Neuroimaging in human dystonia.

Authors:  Kotaro Asanuma; Maren Carbon-Correll; David Eidelberg
Journal:  J Med Invest       Date:  2005-11

3.  Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia.

Authors:  A Münchau; D Mathen; T Cox; N P Quinn; C D Marsden; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 4.  Update on the pathology of dystonia.

Authors:  David G Standaert
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

Review 5.  Structural, functional and molecular imaging of the brain in primary focal dystonia--a review.

Authors:  E Zoons; J Booij; A J Nederveen; J M Dijk; M A J Tijssen
Journal:  Neuroimage       Date:  2011-02-22       Impact factor: 6.556

Review 6.  Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy.

Authors:  Robert A Stern; David O Riley; Daniel H Daneshvar; Christopher J Nowinski; Robert C Cantu; Ann C McKee
Journal:  PM R       Date:  2011-10       Impact factor: 2.298

Review 7.  Review: genetics and neuropathology of primary pure dystonia.

Authors:  R Paudel; J Hardy; T Revesz; J L Holton; H Houlden
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

8.  Neuronal activity in the basal ganglia and thalamus in patients with dystonia.

Authors:  Ping Zhuang; Yongjie Li; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2004-11       Impact factor: 3.708

Review 9.  Secondary cervical dystonia associated with structural lesions of the central nervous system.

Authors:  Mark S LeDoux; Kimberly A Brady
Journal:  Mov Disord       Date:  2003-01       Impact factor: 10.338

10.  Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia.

Authors:  M Obermann; O Yaldizli; A de Greiff; J Konczak; M L Lachenmayer; F Tumczak; A R Buhl; N Putzki; J Vollmer-Haase; E R Gizewski; H-C Diener; M Maschke
Journal:  Eur J Neurol       Date:  2008-08       Impact factor: 6.089

View more
  1 in total

1.  Traumatic Brain Injury Exposure Lowers Age of Cognitive Decline in AD and Non-AD Conditions.

Authors:  Diego Iacono; Sorana Raiciulescu; Cara Olsen; Daniel P Perl
Journal:  Front Neurol       Date:  2021-05-12       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.